Protexin, Inc.: 2017 Company Profiles
U.K. to the U.S.
With an ongoing commitment to research, and its own cGMP (current good manufacturing practice) accredited manufacturing facility, Protexin is one of the U.K.’s supplement industry’s most established and trusted companies when it comes to probiotics and gut health.
The company is experiencing rapid demand across the globe and exports to 40-plus countries already.
Extensive growth is also being seen from the U.S. market, as more and more vitamin retailers are discovering their portfolio of products and are impressed by their extensive research.
This has lead to Protexin opening a subsidiary in Miami to help cater for this accelerated USA growth.
“Word is spreading around vitamin retailers about the unique probiotic products in the Bio-Kult range,” said Lizzie Hardy, director of marketing and communications. “Having our own offices and warehouse facilities in Miami means we can support our partners in the U.S. more efficiently and above all, maintain the exceptional level of customer service we are known for around the globe.”
As a company, Protexin’s belief is that nature is an ideal source of effective health care solutions, and that applied research and understanding can harness these solutions to the benefit of both humans and animals.
“We manufacture to pharmaceutical MHRA cGMP standards so all our customers around the world can be confident that our products are the highest quality,” explained Janine Barlow, head of new product development.
As a business, Protexin invests a large amount into research, working closely with leading universities, hospitals and research centers around the world on a range of ongoing research programs.
Recent research has been carried out confirming the effectiveness of Bio-Kult Infantis, a product designed especially for babies and children. The study looked at the effects of probiotics on childhood constipation. The randomized controlled, double-blind clinical trial, published in the International Journal of Pediatrics, concluded that there was evidence that the seven strain probiotic mixture used can help to improve stool frequency, stool consistency, abdominal pain and fecal incontinence in children with chronic constipation.
In a another randomized controlled trial, published in the Journal of Pediatrics and Child Health, the seven bacterial strains within Bio-Kult Infantis were shown to significantly improve symptoms in infants suffering with colic. The researchers added that the study supports the case for larger trials to see whether probiotics can prevent infant colic.
Protexin’s investment in research is significant, both in terms of finances but also time; it is a long process, from setting up the study design, then working with the clinical research organizations, then going through ethics and then the actual study. “It is a long and detailed process, it’s a big commitment for us but we believe it is important to put a lot of resources into clinical trials,” said Barlow.
The Bio-Kult line-up of products has grown in recent years, and as well as the original 14-strain live bacteria product, there is also Bio-Kult Candéa, a live bacteria supplement with added grapefruit seed extract and garlic. When taken daily, it can help strengthen the body’s natural defenses against candida.* Bio-Kult Pro-Cyan contains cranberry extract, two specifically selected live bacteria strains and vitamin A, which contributes to the normal function of the immune system and the maintenance of mucous membranes which can be found lining the urinary tract.* The newest addition to the range is Bio-Kult Infantis, an advanced multi-strain formula for babies and young children.
Protexin shows a strong commitment to supporting its retailer partners. Extensive marketing strategies and point of sale support is available. Robust technical expertise to assist with training retail employees and their customers is also available.
“Education is key to our business,” said Hardy. “We are committed to sharing the knowledge we have of the probiotic market. We are proud of our research programs and the uniqueness of our products and we want to share that with as many people as we can.”
Protexin has won the Queen’s Award for International Trade in 2011 and again in 2016 and has been awarded a two-star rating award from Best Companies, which is considered “Outstanding.”
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.